In laboratories, industrial parks and research centres across Europe, a quiet transformation is underway. It is not driven by a single breakthrough or a lone discovery, but by a broader realisation: the future of Europe’s economic resilience, healthcare systems and environmental sustainability may depend on its ability to manufacture biology at scale.
Biotechnology and biomanufacturing, once niche fields, now sit at the heart of Europe’s strategy for economic resilience, healthcare innovation and environmental sustainability. Recognised by the European Commission as a critical technology for both economic security and technological sovereignty, the sector has grown rapidly, with productivity and output far outpacing the wider EU economy over the past decade.
Yet beneath this promise lies a structural challenge.
A continent divided by innovation
Europe’s strength in science is undisputed. Its weakness, however, lies in uneven translation turning research into scalable, market-ready solutions.
While regions such as Catalonia have built highly integrated innovation ecosystems where academia, industry and government operate in synchrony, others, particularly in Southern and Eastern Europe, remain fragmented. High-quality research exists, as does industrial capacity. What is often missing is cohesion: the connective tissue that enables ideas to travel from laboratory benches to production lines.
This disparity often described as Europe’s “innovation divide” risks creating a two-speed continent, where opportunity concentrates in established hubs while emerging regions struggle to capitalise on their potential.
It is precisely this gap that the BRIDGE project seeks to address.
From fragmentation to connection
BRIDGE (Biomanufacturing Regional Innovation and Development for Growth and Excellence) is not merely another collaborative initiative. It is a structural intervention designed to rebalance Europe’s innovation landscape.
Its premise is simple: connect regions with complementary strengths and enable them to grow together. The project links Catalonia – one of Europe’s leading bio-innovation ecosystems with two high-potential regions, Silesia in Poland and Campania in Italy, creating a corridor for knowledge, expertise and investment to flow in both directions.
Rather than replicating models wholesale, BRIDGE focuses on adaptation, transferring proven practices while aligning them with local contexts and Smart Specialisation Strategies (S3). The aim is not uniformity, but interoperability: ecosystems that can collaborate effectively while retaining their unique strengths.
As Cluster Campania Bioscience notes:
“Campania holds exceptional scientific and industrial capabilities, yet these strengths have often operated in isolation. BRIDGE allows us to transform this potential into a coordinated ecosystem, one that connects research excellence with real investment pathways and European opportunities.”
Three regions, one shared trajectory
The strength of BRIDGE lies in the diversity of its partners. Catalonia serves as a benchmark, a mature ecosystem with a well-functioning “triple helix” model linking public authorities, academia and industry. Its role is not only to share expertise, but to demonstrate how strategic coordination can accelerate innovation. Through organisations such as Biocat, this knowledge becomes actionable:
“Catalonia’s experience shows that innovation does not happen in isolation. It is built through long-term collaboration between sectors. Through BRIDGE, we are transferring not just knowledge, but a mindset: how to structure ecosystems like the BioRegion of Catalonia that consistently turn research into real-world solutions.”
In contrast to other regions, Silesia stands out as a region in transformation – one with strong industrial roots that is now steadily redefining its role as a hub for advanced technologies, including biomanufacturing. This process represents both a challenge and a strategic development opportunity:
“Its research base, skilled workforce, R&D infrastructure, and deeply embedded culture of production provide a solid foundation for this transition. Through the BRIDGE project, this potential can be translated into the development of a highly specialised biomanufacturing sector – by integrating regional assets, strengthening interregional collaboration, and fostering mutual learning based on complementary strengths’’
GAPR, Upper Silesian Accelerator for Commercial Enterprises – coordinator of MedSilesia Cluster
In Campania, the large number of pharmaceutical companies, universities, and research centers represents a significant strength. On the other hand, however, the innovation ecosystem is still too fragmented and struggles to achieve proper recognition due to the limited presence of investors and infrastructures capable of unlocking its full potential.
Building more than networks
What sets BRIDGE apart is its operational depth. It moves beyond dialogue to implementation – mapping ecosystems, identifying value chain gaps and directly connecting industry challenges with solution providers. At the same time, it delivers targeted training and builds pipelines of investment-ready projects aligned with regional and European funding.
Crucially, BRIDGE turns policy into practice, translating Smart Specialisation Strategies into concrete roadmaps and real investment opportunities.
The ambition is clear: not just cooperation, but measurable outcomes – new partnerships, scalable innovation and projects ready to reach the market.
Why it matters now
The timing of BRIDGE is not incidental. Europe faces increasing pressure to secure its supply chains, reduce external dependency and compete in critical technologies. Biomanufacturing sits at the intersection of these challenges, offering solutions that are both economically valuable and strategically essential.
A bridge, not a destination
If there is a defining feature of BRIDGE, it is that it is designed as a process rather than an endpoint. Its success will not be measured solely by the connections it creates, but by the ecosystems it leaves behind – stronger, more integrated and better equipped to compete on a global stage.
In that sense, BRIDGE is both a metaphor and a mechanism. It connects regions, aligns ambitions and, perhaps most importantly, demonstrates that Europe’s innovation future does not lie in isolated excellence, but in shared progress.